We are live on ! Find out more
LIAN

LianBio American Depositary Shares
LIAN

Delisted

LIAN was delisted on the 18th of March, 2024.

Back to rankings

2 hedge funds and large institutions have $50.5K invested in LianBio American Depositary Shares in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

12% more capital invested

Capital invested by funds: $45.2K → $50.5K (+$5.28K)

33% less funds holding

Funds holding: 3 → 2 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$7.01K

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$4.72K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$46.5K +$7.01K +22,264 +18%
FIA
2
FNY Investment Advisers
New York
$4K – – –
Goldman Sachs
3
Goldman Sachs
New York
– -$4.72K -14,621 Closed

LIAN Hedge Fund Activity: Q2 2024 in Review

2 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q2 2024, worth a combined $50.5K — up 12% from $45.2K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of LIAN and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was RhumbLine Advisers, adding an estimated $7.01K. The largest seller was Goldman Sachs, exiting entirely with an estimated $4.72K sold.

  • 2 institutional investors held LianBio American Depositary Shares (LIAN) as of Q2 2024, down from 3 in Q1 2024.
  • Funds reported $50.5K of LianBio American Depositary Shares stock for Q2 2024, up 12% quarter-over-quarter.
  • 0 funds opened new LianBio American Depositary Shares positions in Q2 2024 and 1 closed out, a net change of -1 holder.
  • The largest LianBio American Depositary Shares buyer in Q2 2024 was RhumbLine Advisers, an estimated $7.01K added.
  • The largest LianBio American Depositary Shares seller in Q2 2024 was Goldman Sachs, an estimated $4.72K sold.

Based on aggregated 13F filings for Q2 2024.